Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9855 |
BR102910
4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]- |
Others | Others |
BR102910 (4-Thiazolecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-2-[(3,4-dichlorophenyl)methyl]-) 是一种选择性的成纤维细胞活化蛋白(FAP)的抑制剂。 | |||
T7890 |
SP-13786
UAMC-1110,(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺 |
Others | Others |
SP-13786 (UAMC-1110) 是成纤维细胞活化蛋白 (FAP) 的抑制剂 (IC50 : 3.2 nM);还抑制脯氨酰寡肽酶 (PREP) ( IC50 : 1.8 μM)。 | |||
T78214 |
FAP-IN-2 TFA
|
||
FAP-IN-2 TFA为99mTc标记的异腈类FAP抑制剂衍生物,适用于肿瘤显像。 | |||
T11263 |
FAPI-2
|
Others | Others |
Fapi-2 is a fibroblast activated protein (FAP) inhibitor used in cancer research. | |||
T35852 |
FAPI-34
|
||
FAPI-34, a fibroblast-activating protein (FAP) inhibitor, boasts advantageous pharmacokinetic and biochemical attributes. | |||
T10227 |
Ac-Gly-BoroPro
|
Others | Others |
Ac-Gly-BoroPro is a selective FAP inhibitor (Ki: 23 nM). | |||
T69603 |
BR103354
|
||
BR103354 is a novel fibroblast activation protein (FAP) inhibitor with anti-diabetic and anti-steatotic effects. BR103354 inhibited FAP with an IC50 value of 14 nM, showing high selectivity against dipeptidyl peptidase (DPP)-related enzymes and prolyl oligopeptidase (PREP). BR103354 exhibited good pharmacokinetic properties as evidenced by oral bioavailability of 48.4% and minimal hERG inhibition. Single co-administration of BR103354 with hFGF21 reduced nonfasting blood glucose concentrations, i... | |||
T11264 |
FAPI-4
|
Others | Others |
Api-4 is a fibroblast activated protein (FAP) inhibitor used in cancer research. | |||
T78921 |
FAP-IN-1
|
||
FAP-IN-1,一种FAP (成纤维细胞激活蛋白)抑制剂,具有3.3 nM的IC50值,适用于癌症研究。 | |||
T74402 |
FAP-PI3KI1
|
||
FAP-PI3KI1 是一种成纤维细胞活化蛋白 (FAP) 靶向 PI3K 抑制剂,可选择性靶向表达 FAP 的人特发性肺纤维化 (IPF)细胞并有效抑制胶原蛋白合成,减少胶原蛋白沉积。 | |||
T82416 |
FAPI-2 TFA
|
||
FAPI-2 TFA为一种针对成纤维细胞活化蛋白(FAP)的抑制剂,适用于癌症研究领域。 | |||
T69660 |
NOTA-FAPI-4
|
||
NOTA-FAPI-4 is an analogue of FAPI-4 and a fibroblast activation protein (FAP) inhibitor. NOTA-FAPI-4 is useful in the diagnosis or treatment of a disease characterized by overexpression of fibroblast activation protein (FAP). NOTA-FAPI-4 can be used as a PET tracer for detection of diseases or disorders related to fibroblast activation protein. | |||
T79917 |
FAP-IN-2
|
||
FAP-IN-2,一种标记有99mTc的含异腈FAPI(成纤维细胞活化蛋白)抑制剂衍生物,适用于肿瘤显像。 | |||
T78179 |
NH2-UAMC1110 TFA
|
||
NH2-UAMC1110 TFA 是 UAMC1110 的一个衍生物,用于合成 FAPI-QS。UAMC1110 是成纤维细胞激活蛋白(FAP)的抑制剂,而 FAPI-QS 作为螯合剂,用于制备特异性高、剂量大的放射性示踪剂,适用于肿瘤的诊断与治疗。 | |||
T37861 |
Talabostat
|
||
Talabostat (PT100, Val-boroPro) is a potent, nonselective and orally available dipeptidyl peptidase IV (DPP-IV) inhibitor with a Ki of 0.18 nM. Talabostat is a nonselective DPP-IV inhibitor, inhibiting DPP8/9, FAP, DPP2 and some other DASH family enzymes essentially as potently as it inhibits DPP-IV[1]. Talabostat stimulates the immune system by triggering a proinflammatory form of cell death in monocytes and macrophages known as pyroptosis. The inhibition of two serine proteases, DPP8 and DPP9,... |